Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Endometrial Neoplasms × enfortumab vedotin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Transitional Cell 8 Urinary Bladder Neoplasms 4 Ureteral Neoplasms 3 Neoplasm Metastasis 2 Metastatic Urothelial Cancer 2 Urologic Neoplasms 1 Urethral Neoplasms 1 Urachal adenocarcinoma 1 Triple Negative Breast Neoplasms 1 Salivary Gland Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Penile Squamous Cell Carcinoma (PSCC) 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Muscle-invasive Bladder Cancer 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Metastatic Castration-resistant Prostate Cancer 1 Melanoma 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma, Adenoid Cystic 1 Breast Neoplasms 1

Interventions

Paclitaxel 31 Carboplatin 24 pembrolizumab 17 Bevacizumab 15 Letrozole 13 Cisplatin 9 Megestrol Acetate 8 dostarlimab 7 olaparib 6 lenvatinib 6 abemaciclib 6 Metformin 6 durvalumab 5 Radiotherapy 5 Gemcitabine 5 Fluorouracil 5 Everolimus 5 Docetaxel 5 temsirolimus 4 rucaparib 4 niraparib 4 Specimen Handling 4 Oxaliplatin 4 Nivolumab 4 Medroxyprogesterone Acetate 4 Magnetic Resonance Spectroscopy 4 Fulvestrant 4 Doxorubicin 4 ridaforolimus 3 mirvetuximab soravtansine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07139977 2026-01-20

EV-4-EC

Medical College of Wisconsin

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡